• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从基于知识的势能到计算机辅助组合先导设计

From knowledge-based potentials to combinatorial lead design in silico.

作者信息

Grzybowski Bartosz A, Ishchenko Alexey V, Shimada Jun, Shakhnovich Eugene I

机构信息

Concurrent Pharmaceuticals, 1 Broadway, 14th floor, Cambridge, Massachusetts 02142, USA.

出版信息

Acc Chem Res. 2002 May;35(5):261-9. doi: 10.1021/ar970146b.

DOI:10.1021/ar970146b
PMID:12020163
Abstract

Computational methods are becoming increasingly used in the drug discovery process. In this Account, we review a novel computational method for lead discovery. This method, called CombiSMoG for "combinatorial small molecule growth", is based on two components: a fast and accurate knowledge-based scoring function used to predict binding affinities of protein-ligand complexes, and a Monte Carlo combinatorial growth algorithm that generates large numbers of low-free-energy ligands in the binding site of a protein. We illustrate the advantages of the method by describing its application in the design of picomolar inhibitors for human carbonic anhydrase.

摘要

计算方法在药物发现过程中的应用越来越广泛。在本综述中,我们介绍一种用于先导化合物发现的新型计算方法。这种方法称为CombiSMoG(“组合小分子生长”),基于两个部分:一个快速准确的基于知识的评分函数,用于预测蛋白质-配体复合物的结合亲和力;以及一个蒙特卡罗组合生长算法,该算法在蛋白质的结合位点生成大量低自由能配体。我们通过描述其在设计人碳酸酐酶皮摩尔抑制剂中的应用来说明该方法的优势。

相似文献

1
From knowledge-based potentials to combinatorial lead design in silico.从基于知识的势能到计算机辅助组合先导设计
Acc Chem Res. 2002 May;35(5):261-9. doi: 10.1021/ar970146b.
2
Combinatorial computational method gives new picomolar ligands for a known enzyme.组合计算方法为一种已知酶提供了新的皮摩尔级配体。
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1270-3. doi: 10.1073/pnas.032673399. Epub 2002 Jan 29.
3
Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin.动态配体设计与组合优化:内皮硫素蛋白酶抑制剂的设计
Proteins. 2000 Aug 1;40(2):258-89.
4
Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery.蛋白质导向的动态组合化学:蛋白质配体与抑制剂发现指南
Molecules. 2016 Jul 16;21(7):910. doi: 10.3390/molecules21070910.
5
Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.基于建模与实验的组合方法进行配体设计:应用于HLA - DR4
J Comput Aided Mol Des. 2007 Jul;21(7):395-418. doi: 10.1007/s10822-007-9119-x. Epub 2007 Jul 27.
6
Computational combinatorial ligand design: application to human alpha-thrombin.计算组合配体设计:在人α-凝血酶中的应用。
J Comput Aided Mol Des. 1996 Oct;10(5):372-96. doi: 10.1007/BF00124471.
7
PREDICT modeling and in-silico screening for G-protein coupled receptors.针对G蛋白偶联受体的PREDICT建模与计算机模拟筛选
Proteins. 2004 Oct 1;57(1):51-86. doi: 10.1002/prot.20195.
8
Lead optimization via high-throughput molecular docking.通过高通量分子对接进行先导化合物优化。
Curr Opin Drug Discov Devel. 2007 May;10(3):264-74.
9
HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.用于大分子数据库虚拟配体筛选的HierVLS分层对接协议。
J Med Chem. 2004 Jan 1;47(1):56-71. doi: 10.1021/jm030271v.
10
Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis.利用烯烃复分解反应的动态组合化学进行碳酸酐酶II抑制剂的基于片段的药物发现。
Bioorg Med Chem. 2006 May 15;14(10):3275-84. doi: 10.1016/j.bmc.2005.12.054. Epub 2006 Jan 20.

引用本文的文献

1
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.用于改善新冠病毒疾病治疗的药物遗传学和精准医学方法。
Front Pharmacol. 2022 Feb 18;13:835136. doi: 10.3389/fphar.2022.835136. eCollection 2022.
2
Using diverse potentials and scoring functions for the development of improved machine-learned models for protein-ligand affinity and docking pose prediction.利用多样化的势能和评分函数,开发改进的基于机器学习的蛋白质-配体亲和力和对接构象预测模型。
J Comput Aided Mol Des. 2021 Nov;35(11):1095-1123. doi: 10.1007/s10822-021-00423-4. Epub 2021 Oct 28.
3
DLIGAND2: an improved knowledge-based energy function for protein-ligand interactions using the distance-scaled, finite, ideal-gas reference state.
DLIGAND2:一种基于知识的改进型能量函数,用于蛋白质-配体相互作用,采用距离缩放的有限理想气体参考态。
J Cheminform. 2019 Aug 7;11(1):52. doi: 10.1186/s13321-019-0373-4.
4
Rational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.合理鉴定依诺沙星为新型 V-ATPase 靶向性破骨细胞抑制剂。
Curr Protein Pept Sci. 2012 Mar;13(2):180-91. doi: 10.2174/138920312800493151.
5
An interaction-motif-based scoring function for protein-ligand docking.基于相互作用基元的蛋白质-配体对接打分函数。
BMC Bioinformatics. 2010 Jun 2;11:298. doi: 10.1186/1471-2105-11-298.
6
Solvent accessible surface area approximations for rapid and accurate protein structure prediction.用于快速准确蛋白质结构预测的溶剂可及表面积近似值。
J Mol Model. 2009 Sep;15(9):1093-108. doi: 10.1007/s00894-009-0454-9. Epub 2009 Feb 21.
7
Protein folding thermodynamics and dynamics: where physics, chemistry, and biology meet.蛋白质折叠的热力学与动力学:物理、化学和生物学的交汇之处。
Chem Rev. 2006 May;106(5):1559-88. doi: 10.1021/cr040425u.
8
Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces.基于蛋白质-配体界面新型几何化学描述符的定量结构-结合亲和力关系模型的开发。
J Med Chem. 2006 May 4;49(9):2713-24. doi: 10.1021/jm050260x.
9
Protein structure and evolutionary history determine sequence space topology.蛋白质结构和进化历史决定序列空间拓扑结构。
Genome Res. 2005 Mar;15(3):385-92. doi: 10.1101/gr.3133605.
10
A new hydrogen-bonding potential for the design of protein-RNA interactions predicts specific contacts and discriminates decoys.一种用于蛋白质-RNA相互作用设计的新型氢键势可预测特定相互作用并区分诱饵。
Nucleic Acids Res. 2004 Sep 30;32(17):5147-62. doi: 10.1093/nar/gkh785. Print 2004.